PLATON Trademark

Trademark Overview


On Friday, March 9, 2018, a trademark application was filed for PLATON with the United States Patent and Trademark Office. The USPTO has given the PLATON trademark a serial number of 79235070. The federal status of this trademark filing is REGISTERED as of Tuesday, December 25, 2018. This trademark is owned by ONXEO. The PLATON trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Products for medical use, namely, pharmaceutical products for use in oncology, especially oligonucleotides, more particularly in the form of double-stranded DNA acting as a decoy or false signal for proteins, especially enzymes, involved in tumor growth and/or tumor escape, more particularly DNA binding proteins and especially tumor cell DNA repair proteins for treating solid and/or liquid cancers

Scientific, medical and pharmaceutical research for the research and identification of new pharmaceutical products limited to these oligonucleotides from a proprietary technology platform or chemo-library; pharmaceutical research and development limited to products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory research limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory analysis limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library
platon

General Information


Serial Number79235070
Word MarkPLATON
Filing DateFriday, March 9, 2018
Status700 - REGISTERED
Status DateTuesday, December 25, 2018
Registration Number5635338
Registration DateTuesday, December 25, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 9, 2018

Trademark Statements


Goods and ServicesProducts for medical use, namely, pharmaceutical products for use in oncology, especially oligonucleotides, more particularly in the form of double-stranded DNA acting as a decoy or false signal for proteins, especially enzymes, involved in tumor growth and/or tumor escape, more particularly DNA binding proteins and especially tumor cell DNA repair proteins for treating solid and/or liquid cancers
Goods and ServicesScientific, medical and pharmaceutical research for the research and identification of new pharmaceutical products limited to these oligonucleotides from a proprietary technology platform or chemo-library; pharmaceutical research and development limited to products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory research limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library; laboratory analysis limited to pharmaceutical products based on oligonucleotides from a proprietary technology platform or chemo-library

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 2, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, July 2, 2018
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameValerio Therapeutics S.A.
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Party NameONXEO
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Party NameONXEO
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events


Event DateEvent Description
Monday, December 25, 2023COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 18, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 18, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, April 26, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, April 4, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 4, 2019FINAL DISPOSITION PROCESSED
Monday, March 25, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, December 25, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, October 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 9, 2018PUBLISHED FOR OPPOSITION
Sunday, October 7, 2018NOTIFICATION PROCESSED BY IB
Wednesday, September 19, 2018NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, September 19, 2018NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, September 19, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 8, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 7, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 7, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 7, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 4, 2018REFUSAL PROCESSED BY IB
Monday, July 16, 2018NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, July 16, 2018REFUSAL PROCESSED BY MPU
Friday, July 6, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, July 6, 2018APPLICATION FILING RECEIPT MAILED
Thursday, July 5, 2018NON-FINAL ACTION WRITTEN
Monday, July 2, 2018ASSIGNED TO EXAMINER
Monday, July 2, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 28, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB